hello and welcome to our look ahead to what the the papers will be bringing us tomorrow. with me are the broadcaster henry bonsu and former trade minister lord jones. lovely to have you both back. hi, henry. lovely to have you both back. hi, henry- lovely to have you both back. hi, hen . , .,, hi, henry. hi, digby, good to see ou hi, henry. hi, digby, good to see you again- hi, henry. hi, digby, good to see you again- they hi, henry. hi, digby, good to see you again. they are hi, henry. hi, digby, good to see you again. they are going - hi, henry. hi, digby, good to see you again. they are going to - hi, henry. hi, digby, good to seei you again. they are going to have their own show, you again. they are going to have their own show, they you again. they are going to have their own show, they really - you again. they are going to have their own show, they really are. l you again. they are going to have l their own show, they really are. i m not needed here. right,
of its programme making out of london, over the next six years. a remarkable collection of handwritten letters from diana princess of wales to a friend are being sold at auction to raise money for arts charities. good afternoon and welcome to bbc news. ministers have sought to reassure people about the rollout of the coronavirus vaccine, amid a reduction in supply which means most people in their 40s will now have to wait till may for a jab. the government insists it will still offer all adults their first dose by the end ofjuly but in the commons earlier today the health secretary confirmed supplies would become tighter in the weeks ahead. the bbc understands a delay in the delivery of 5 million doses of the oxford astrazeneca jab from india is one factor. but matt hancock said no vaccine appointments booked would be cancelled and people would still get their second dose as planned. katharine da costa reports. this vaccination centre in south west london is one of hundreds
takes place. thank you very much forjoining me. welcome to our viewers on pbs in america and around the globe. let s start with the astrazeneca vaccine. the european medicines agency has been examining its safety after more than a dozen eu members suspended it this week over health concerns. and today, we heard its verdict. the committee has come to a clear scientific conclusion. this is a safe and effective vaccine. its benefits in protecting people from covid i9 with the associated risks of death and hospitalisation outweigh the possible risks. the committee also concluded that the vaccine is not associated with an increase in the overall risk of thromboembolic events or blood clots. that press conference took place in amsterdam, and our correspondent jean mackenzie was there. what they ve been saying all along stands, that they think this is a vaccine in which the benefits massively outweigh the risks. it was striking, they pointed out there how many people have died in th